Amicus Therapeutics Inc. (FOLD) |
|
12.31 0.47 (3.97%)
|
05-21 16:00 |
|
Open: |
11.92 |
Pre. Close: |
11.84 |
|
High:
|
12.31 |
Low:
|
11.76 |
|
Volume:
|
1,472,681 |
Market Cap:
|
2837M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
12.316 - 12.377 |
12.377 - 12.438 |
|
Low:
|
11.62 - 11.682 |
11.682 - 11.744 |
|
Close:
|
12.208 - 12.309 |
12.309 - 12.411 |
|
|
|
Technical analysis |
as of: 2019-05-21 4:27:04 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 15.56  One year: 16.69 |
| Support: |
Support1: 11.76 Support2: 9.78 |
| Resistance: |
Resistance1: 13.32 Resistance2: 14.29 |
| Pivot: |
12.91 |
| Moving Average: |
MA(5): 12.30 MA(20): 13.01
MA(100): 12.52 MA(250): 12.93 |
| MACD: |
MACD(12,26): -0.33 Signal(9): -0.21 |
| Stochastic oscillator: |
%K(14,3): 11.03 %D(3): 14.09 |
| RSI: |
RSI(14): 41.80 |
| 52-week: |
High: 17.62 Low: 8.27 Change(%): -20.8 |
| Average Vol(K): |
3-Month: 304637 10-Days: 264608 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.FOLD has closed above bottom band by 28.7%. Bollinger Bands are 30% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 13 May 2019 19:07:09 Z
FOLD Makes Notable Cross Below Critical Moving Average
Thu, 09 May 2019 21:54:45 Z
Amicus' (FOLD) Earnings & Revenues Miss Estimates in Q1
Wed, 08 May 2019 21:58:08 Z
Amicus Therapeutics Inc (FOLD) Q1 2019 Earnings Call Transcript
Wed, 08 May 2019 14:17:44 Z
Amicus Therapeutics (FOLD) Reports Q1 Loss, Lags Revenue Estimates
Fri, 03 May 2019 16:13:24 Z
What's in Store for Catalyst Pharma (CPRX) Q1 Earnings?
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
230.45 |
| Shares Float (M) |
227.68 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
|
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-1.330 |
|
EPS Est. Current Year
|
-1.320 |
|
EPS Est. Next Year
|
-1.020 |
|
EPS Est. Next Quarter
|
-0.290 |
|
Forward EPS
|
-0.920 |
|
Book Value (p.s.)
|
6.420 |
|
PEG Ratio
|
-0.06 |
|
Profit Margin
|
|
|
Operating Margin
|
-322.57 |
|
Return on Assets (ttm)
|
-51.3 |
|
Return on Equity (ttm)
|
-86.2 |
|
Qtrly Rev. Growth
|
103.9 |
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-328.98 |
|
Levered Free Cash Flow (M)
|
-286.37 |
Stock Valuations |
|
P/E
|
-9.26 |
|
P/E Growth Ratio
|
0.04 |
|
P/BV
|
1.92 |
|
P/S
|
5065784832.00 |
|
P/CF
|
-8.62 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
